UPDATE : Wednesday, January 17, 2018
상단여백
What are doctors’ views on Invossa used even by foreign patients? by Lee Hye-seon 2017-11-29 09:31
Green Cross, Feldan start joint tech development by Lee Han-soo 2017-11-27 16:59
Foreigners dump Medytox, Hugel; buy Celltrion, ViroMed by Nam Doo-hyun 2017-11-27 13:13
Biogen Korea taps new CEO by Marian Chu 2017-11-27 11:57
Clinical trials on CAR-T cell therapies surge in two years by Nam Doo-hyun 2017-11-24 15:53
라인
Kolon okayed for clinical trial to expand treatment for Invossa-K injection by Lee Han-soo 2017-11-23 15:53
GemVax & KAEL confirms potential tracer effective to reperfusion injury by Constance Williams 2017-11-22 15:51
COGIB spotlights future of innovative biotherapeutic by Lee Han-soo 2017-11-22 11:06
KAEL confirms potential tracer as treatment for kidney cancer by Constance Williams 2017-11-20 15:44
Samsung Bioepis wins European sales approval for Ontruzant by Lee Han-soo 2017-11-20 10:48
라인
ViroMed aims phase 1 trial on CAR-T cell therapy by 2020-2022 by Nam Doo-hyun 2017-11-17 13:53
Earthquake hits biopharmaceutical factories in Pohang by Nam Doo-hyun 2017-11-16 15:55
J&J struggles to maintain market dominance of Remicade by Lee Han-soo and Nam Doo-hyun 2017-11-16 10:25
Hugel merges with subsidiaries by Lee Han-soo 2017-11-15 17:51
Macrogen reaffirms diagnostic sequencing capability with CAP certification by Constance Williams 2017-11-15 14:48
라인
Janssen drops suit against Samsung Bioepis on Renflexis by Lee Han-soo 2017-11-14 17:59
Celltrion to test combo therapy of new flu antibody drug, Tamiflu by Lee Hye-seon 2017-11-14 11:38
Biopharmaceutical firms rank high in Kosdaq market cap by Nam Doo-hyun 2017-11-13 15:25
KIST to transfer immune-enhancing tech to EuBiologics by Constance Williams 2017-11-13 12:14
Samsung Bioepis gets sales license for Samfenet by Lee Han-soo 2017-11-09 16:03
여백
여백
여백
Back to Top